• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与肥厚型心肌病相关的室性心动过速:发生率、预后和与肥厚类型的关系。

Ventricular tachyarrhythmia associated with hypertrophic cardiomyopathy: incidence, prognosis, and relation to type of hypertrophy.

机构信息

The First Department of Internal Medicine, Niigata University School of Medicine, Niigata, Japan.

出版信息

J Cardiovasc Electrophysiol. 2010 Sep;21(9):991-9. doi: 10.1111/j.1540-8167.2010.01769.x.

DOI:10.1111/j.1540-8167.2010.01769.x
PMID:20487113
Abstract

OBJECTIVE

To assess the incidence, characteristics, and prognosis of ventricular tachyarrhythmia in hypertrophic cardiomyopathy (HCM).

PATIENTS

The study consisted of 66 consecutive patients with HCM who were admitted to Niigata University Hospital between 1992 and 2005. Their clinical characteristics and ECG morphology were investigated according to the type of HCM.

RESULTS

The type of HCM was asymmetric hypertrophy (ASH) in 34 patients (51%), obstructive HCM (HOCM) in 9 (14%), apical HCM (ApHCM) in 14 (21%), and midventricular obstruction (MVO) in 9 (14%). The cause of admission was ventricular tachyarrhythmia in 25 patients (38%), unexplained syncope in 11 (17%), and heart failure in 30 (45%). Sustained monomorphic ventricular tachycardia (SMVT) occurred in 19 patients and ventricular fibrillation in 6. In the 19 patients with SMVT, 12 had MVO and 3 of these had previous apHCM. Six of the 19 patients with SMVT had ASH, and 3 had abnormal apical wall motion. In 14 patients, the SMVT appeared to originate from the apical aneurysm based on the morphology of the tachycardia. Ventricular tachyarrhythmia recurred in 14 of the 25 patients (56%), and 4 of the 18 patients with an ICD had electrical storm. ASH with abnormal wall motion of the LV apex or MVO was recognized in the 4 patients with electrical storm; they commonly had abnormal Q waves and ST elevation in leads V4-V6.

CONCLUSION

Ventricular tachyarrhythmia was responsible for 38% of hospitalizations in HCM, and SMVT occurred in patients with MVO and/or with abnormal wall motion of the LV apex. Electrical storm was more common in patients with ST elevation in precordial leads V4-V6.

摘要

目的

评估肥厚型心肌病(HCM)中室性心动过速的发生率、特征和预后。

患者

本研究纳入了 1992 年至 2005 年期间在新泻大学医院就诊的 66 例连续 HCM 患者。根据 HCM 类型调查了患者的临床特征和心电图形态。

结果

34 例(51%)患者为不对称性肥厚(ASH),9 例(14%)为梗阻性 HCM(HOCM),14 例(21%)为心尖肥厚型心肌病(ApHCM),9 例(14%)为中隔心肌梗阻(MVO)。25 例(38%)患者因室性心动过速入院,11 例(17%)因不明原因晕厥入院,30 例(45%)因心力衰竭入院。19 例患者发生持续性单形性室性心动过速(SMVT),6 例患者发生心室颤动。19 例 SMVT 患者中,12 例存在 MVO,其中 3 例之前存在 ApHCM。19 例 SMVT 患者中,6 例为 ASH,3 例存在心尖部异常壁运动。14 例患者的 SMVT 起源于心动过速的形态,根据起源于心尖部的室性心动过速。25 例患者中有 14 例(56%)复发室性心动过速,18 例植入 ICD 的患者中有 4 例发生电风暴。电风暴的 4 例患者中,ASHD 和 LV 心尖部异常壁运动或 MVO 得到识别,他们通常存在 V4-V6 导联异常 Q 波和 ST 段抬高。

结论

在 HCM 患者中,38%的住院患者因室性心动过速引起,SMVT 发生于存在 MVO 和/或 LV 心尖部异常壁运动的患者中。电风暴在 V4-V6 导联存在 ST 段抬高的患者中更常见。

相似文献

1
Ventricular tachyarrhythmia associated with hypertrophic cardiomyopathy: incidence, prognosis, and relation to type of hypertrophy.与肥厚型心肌病相关的室性心动过速:发生率、预后和与肥厚类型的关系。
J Cardiovasc Electrophysiol. 2010 Sep;21(9):991-9. doi: 10.1111/j.1540-8167.2010.01769.x.
2
Hypertrophic cardiomyopathy with midcavitary obstruction: another substrate for ventricular tachycardia?伴有心腔中部梗阻的肥厚型心肌病:室性心动过速的另一种基质?
J Cardiovasc Electrophysiol. 2010 Sep;21(9):1000-1. doi: 10.1111/j.1540-8167.2010.01800.x.
3
QRS Fragmentation and QTc Duration Relate to Malignant Ventricular Tachyarrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy.QRS波离散度和QTc间期与肥厚型心肌病患者的恶性室性心律失常及心源性猝死相关。
J Cardiovasc Electrophysiol. 2015 May;26(5):547-55. doi: 10.1111/jce.12629. Epub 2015 Mar 27.
4
Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up.肥厚型心肌病患者的植入式心脏复律除颤器:长期随访中的疗效和治疗并发症。
J Cardiovasc Electrophysiol. 2010 Aug 1;21(8):883-9. doi: 10.1111/j.1540-8167.2009.01716.x. Epub 2010 Feb 1.
5
Appropriate Implantable Defibrillator Therapy in Adults With Hypertrophic Cardiomyopathy.肥厚型心肌病成人患者的适当植入式心脏除颤器治疗
J Cardiovasc Electrophysiol. 2016 Aug;27(8):953-60. doi: 10.1111/jce.13005. Epub 2016 Jun 1.
6
Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators.肥厚型心肌病和植入式心脏复律除颤器高危患者的临床过程和生活质量。
Circ Arrhythm Electrophysiol. 2018 Apr;11(4):e005820. doi: 10.1161/CIRCEP.117.005820.
7
Eligibility for the Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Hypertrophic Cardiomyopathy.肥厚型心肌病患者植入皮下植入式心律转复除颤器的适应证
J Cardiovasc Electrophysiol. 2015 Aug;26(8):893-899. doi: 10.1111/jce.12714.
8
Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.非梗阻性、易变型和梗阻性肥厚型心肌病患者的临床转归。
J Am Heart Assoc. 2018 Feb 25;7(5):e006657. doi: 10.1161/JAHA.117.006657.
9
Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.植入式心脏复律除颤器对肥厚型心肌病患者预防猝死的疗效。
N Engl J Med. 2000 Feb 10;342(6):365-73. doi: 10.1056/NEJM200002103420601.
10
[Mid-ventricular obstructive hypertrophic cardiomyopathy associated with an apical aneurysm and sustained ventricular tachycardia: a case report].[伴心尖部动脉瘤及持续性室性心动过速的心室中部梗阻性肥厚型心肌病:一例报告]
J Cardiol. 2001 Dec;38(6):343-9.

引用本文的文献

1
Electrophysiological mechanisms underlying T wave pseudonormalisation on stress ECGs in hypertrophic cardiomyopathy.应激心电图中肥厚型心肌病 T 波假性正常化的电生理机制。
Comput Biol Med. 2024 Feb;169:107829. doi: 10.1016/j.compbiomed.2023.107829. Epub 2023 Dec 7.
2
Mid-ventricular obstructive hypertrophic cardiomyopathy with apical aneurysm: An important subtype of arrhythmogenic cardiomyopathy.伴心尖部室壁瘤的心室中部梗阻性肥厚型心肌病:致心律失常性心肌病的一种重要亚型。
Ann Noninvasive Electrocardiol. 2019 Sep;24(5):e12638. doi: 10.1111/anec.12638. Epub 2019 Feb 9.
3
Relationship between Extension or Texture Features of Late Gadolinium Enhancement and Ventricular Tachyarrhythmias in Hypertrophic Cardiomyopathy.
肥厚型心肌病晚期钆增强的延伸或纹理特征与室性心律失常的关系。
Biomed Res Int. 2018 Sep 9;2018:4092469. doi: 10.1155/2018/4092469. eCollection 2018.
4
Decompensated Heart Failure With Ventricular Arrhythmia: How Useful Is VT Ablation?失代偿性心力衰竭合并室性心律失常:室性心动过速消融术有多大作用?
Curr Heart Fail Rep. 2018 Aug;15(4):201-213. doi: 10.1007/s11897-018-0395-7.
5
Novel trigenic CACNA1C/DES/MYPN mutations in a family of hypertrophic cardiomyopathy with early repolarization and short QT syndrome.肥厚型心肌病伴早期复极和短QT综合征家族中的新型三基因CACNA1C/DES/MYPN突变
J Transl Med. 2017 Apr 20;15(1):78. doi: 10.1186/s12967-017-1180-1.
6
Association of ST elevation with apical aneurysm in hypertrophic cardiomyopathy.肥厚型心肌病中ST段抬高与心尖部室壁瘤的关联
Indian Heart J. 2015 Sep-Oct;67(5):434-9. doi: 10.1016/j.ihj.2015.05.019. Epub 2015 Aug 8.
7
Dual chamber pacing relieves obstruction in Japanese-variant hypertrophic cardiomyopathy.双腔起搏治疗日本变异型肥厚型心肌病梗阻。
Am J Ther. 2013 Sep-Oct;20(5):588-90. doi: 10.1097/MJT.0b013e31821109ff.
8
Two hundred eight patients with apical hypertrophic cardiomyopathy in china: clinical feature, prognosis, and comparison of pure and mixed forms.中国 208 例心尖肥厚型心肌病患者:临床特征、预后及单纯与混合形式的比较。
Clin Cardiol. 2012 Feb;35(2):101-6. doi: 10.1002/clc.20995. Epub 2011 Nov 28.